Barry S. Skikne
Direttore/Membro del Consiglio presso TVAX BIOM
Posizioni attive di Barry S. Skikne
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TVAX BIOM | Direttore/Membro del Consiglio | 01/12/2011 | - |
| Independent Dir/Board Member | 01/12/2011 | - |
Storia della carriera di Barry S. Skikne
Precedenti posizioni note di Barry S. Skikne
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Kansas | Corporate Officer/Principal | 01/07/2007 | 01/07/2007 |
Formazione di Barry S. Skikne
| University of the Witwatersrand | Undergraduate Degree |
| University of South Africa | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Sud Africa | 3 |
Posizioni
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
- Borsa valori
- Insiders
- Barry S. Skikne
- Esperienza
